Dr Paul Sinclair Dr Ruth Cranston Prahlad Raninga Joanna Cheng Rebecca Hanna et al. | Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia | 2023 |
|
Sarra Ryan Dr Ruth Cranston Claire Schwab Dr Matthew Bashton Dr Paul Sinclair et al. | The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 | 2023 |
|
Dr Deepali Pal Dr Helen Blair Sean Hockney Dr Melanie Beckett Mankaran Singh et al. | hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia | 2022 |
|
Emeritus Professor Amritpal Hungin Dr Paul Sinclair
| Knowledge gaps in the management of refractory reflux-like symptoms: Healthcare provider survey | 2022 |
|
Dr Paul Sinclair Dr Sarra Ryan Dr Matthew Bashton Shaun Hollern Rebecca Hanna et al. | SH2B3 inactivation through CN-LOH-12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain | 2019 |
|
Dr Ruth Cranston Dr Paul Sinclair Dr Matthew Bashton Dr Matthew Selby Professor Christine Harrison FRCPath FMedSci et al. | A Genome-Wide CRISPR Screen Implicates MYC Dysregulation in TCF3-PBX1 B-ALL | 2018 |
|
Dr Paul Sinclair Dr Helen Blair Dr Sarra Ryan Dr Lars Buechler Joanna Cheng et al. | Dynamic clonal progression in xenografts of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 | 2018 |
|
Zach Dixon Dr Lindsay Nicholson Elizabeth Matheson Dr Paul Sinclair Professor Christine Harrison FRCPath FMedSci et al. | CREBBP knockdown enhances RAS/RAF/MEK/ERK signaling in Ras pathway mutated acute lymphoblastic leukemia but does not modulate chemotherapeutic response | 2017 |
|
Dr Alex Elder Dr Klaus Rehe Dr Simon Bomken Dr Paul Sinclair Katie Dormon et al. | The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts. | 2016 |
|
Dr Sarra Ryan Elizabeth Matheson Dr Paul Sinclair Dr Matthew Bashton Claire Schwab et al. | The role of the RAS pathway in iAMP21-ALL | 2016 |
|
Dr Paul Sinclair Joanna Cheng Prahlad Raninga Rebecca Hanna Shaun Hollern et al. | A Targeted Functional Clone Tracking Assay for the Identification of Tumour Suppressor Genes in BCP- ALL Implicates the Transcription Factors FOXO3 and PRDM1 | 2015 |
|
Dr Klaus Rehe Dr Simon Bomken Dr Paul Sinclair Dr Lisa Russell Professor Olaf Heidenreich et al. | Childhood pre-B acute lymphoblastic leukaemia cells capable of central nervous system engraftment are common, heterogeneous and transit the blood-cerebrospinal fluid barrier | 2015 |
|
Dr Jeyanthy Eswaran Dr Paul Sinclair Professor Olaf Heidenreich Professor Julie Irving Dr Lisa Russell et al. | The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia | 2015 |
|
Claire Schwab Sarra Ryan Professor Anthony Moorman Dr Richard McNally Professor Bryan Young et al. | Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia | 2014 |
|
Dr Jeyanthy Eswaran Dr Paul Sinclair Dr Sirintra Nakjang Professor Christine Harrison FRCPath FMedSci
| Identification of Cmtm Family Proteins As Tumor Suppressor and Membrane Regulator in B Cell Precursor Acute Lymphoblastic Leukemia | 2014 |
|
Jake Clayton Joanna Cheng Dr Sarra Ryan Professor Christine Harrison FRCPath FMedSci Dr Paul Sinclair et al. | Oncogenomic Screening Strategies to Identify Tumour Suppressor Genes on Chromosome 12 in Acute Myeloid Leukaemia | 2014 |
|
Dr Paul Sinclair Dr Vikki Rand Hannah Ensor Professor Christine Harrison FRCPath FMedSci
| Analysis of a breakpoint cluster reveals insight into the mechanism of intrachromosomal amplification in a lymphoid malignancy | 2011 |
|
Dr Vikki Rand Dr Lisa Russell Claire Schwab Hannah Ensor Professor Julie Irving et al. | Genomic characterization implicates iAMP21 as a likely primary genetic event in childhood B-cell precursor acute lymphoblastic leukemia | 2011 |
|
Dr Paul Sinclair
| Dynamic plasticity of large -scale chromatin structure revealed by self-assembly of engineered chromosome regions | 2010 |
|
Dr Paul Sinclair
| Insights into interphase large-scale chromatin structure from analysis of engineered chromosome regions | 2010 |
|
Dr Vikki Rand Dr Lisa Russell Professor Julie Irving Lisa Jones Dr Dino Masic et al. | What Is the Initiating Mechanism of iAMP21 in Childhood B Cell Precursor ALL? | 2009 |
|
Dr Paul Sinclair
| The facultative heterochromatin of the inactive X chromosome has a distinctive condensed ultrastructure | 2008 |
|
Dr Paul Sinclair Professor Christine Harrison FRCPath FMedSci
| Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36) | 2005 |
|
Dr Paul Sinclair Professor Christine Harrison FRCPath FMedSci
| A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia: identification and analysis of a candidate tumor suppressor gene | 2004 |
|
Dr Paul Sinclair Dr Bridget Wilkins
| Identification of four new translocations involving FGFR1 in myeloid disorders | 2001 |
|
Dr Paul Sinclair
| Transcription factor BACH2 is transcriptionally regulated by the BCR/ABL oncogene | 2001 |
|
Dr Paul Sinclair Professor Christine Harrison FRCPath FMedSci
| Deletion of 6q16-q21 in human lymphoid maligancies: a mapping and deletion analysis | 2000 |
|
Dr Paul Sinclair
| Large deletions at the t(9;22) breakpoint are common and may define a poor-prognosis subgroup of patients with chronicmyeloid leukemia | 2000 |
|
Dr Paul Sinclair
| Comparative analysis of G-banding, chromosome painting, locus specific FISH and CGH in chronic myeloid leukemia blast chrisis | 1999 |
|
Dr Paul Sinclair
| Achievement of complete cytogenetic remission after two very low-dose doner leucocyte infusions in a patient with extensive cGVHD relapsing in accelerated phase post allogeneic BMT for CML | 1998 |
|
Dr Paul Sinclair
| Improved sensitivity of BCR-ABL detection: a triple-probe three colour fluorescence in situ hybridisation system. | 1997 |
|
Dr Paul Sinclair
| t(9;13)(q34;q12) chromosomal translocation persisting 4 years post autologous bone marrow transplantation for secondary AML despite morphological remission | 1996 |
|
Dr Paul Sinclair
| Denovo ring chromosome 3: a new case with a mild phenotype | 1991 |
|